{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:45:06Z","timestamp":1792665906937,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.08.006","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T10:28:35Z","timestamp":1282127315000},"page":"6901-6914","source":"Crossref","is-referenced-by-count":36,"title":["Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1"],"prefix":"10.1016","volume":"28","author":[{"given":"William M.","family":"Gwinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun M.","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Ashcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil L.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Doil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Tlusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Hollingshead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Briles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Dondero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Michael","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman F.","family":"Staats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April (1)","key":"10.1016\/j.vaccine.2010.08.006_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","article-title":"Needle-free vaccine delivery","volume":"58","author":"Giudice","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"May (15\u201316)","key":"10.1016\/j.vaccine.2010.08.006_bib0480","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.vaccine.2004.01.008","article-title":"Technologies that make administration of vaccines safer","volume":"22","author":"Clements","year":"2004","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2010.08.006_bib0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/00002018-200124140-00001","article-title":"Technologies to improve immunisation safety","volume":"24","author":"Clements","year":"2001","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.006_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm0103-99","article-title":"Can needle-free administration of vaccines become the norm in global immunization?","volume":"9","author":"Levine","year":"2003","journal-title":"Nat Med"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.08.006_bib0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1258\/0956462041211324","article-title":"Declining HIV rates in Uganda: due to cleaner needles, not abstinence or condoms","volume":"15","author":"Brody","year":"2004","journal-title":"Int J STD AIDS"},{"issue":"10","key":"10.1016\/j.vaccine.2010.08.006_bib0030","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull World Health Org"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.08.006_bib0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2672.2006.03112.x","article-title":"Past, imminent and future human medical countermeasures for anthrax","volume":"101","author":"Baillie","year":"2006","journal-title":"J Appl Microbiol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.08.006_bib0040","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1023\/B:PHAM.0000041443.17935.33","article-title":"Novel approaches to vaccine delivery","volume":"21","author":"O\u2019Hagan","year":"2004","journal-title":"Pharm Res"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.08.006_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/17425247.4.5.459","article-title":"Needle-free vaccine delivery","volume":"4","author":"Kersten","year":"2007","journal-title":"Exp Opin Drug Deliv"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.08.006_bib0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/fampra\/cmn069","article-title":"A multifactorial strategy of pain management is associated with less pain in scheduled vaccination of children. A study realized by family practitioners in 239 children aged 4\u201312 years old","volume":"25","author":"Boivin","year":"2008","journal-title":"Fam Pract"},{"issue":"April (Suppl. 5)","key":"10.1016\/j.vaccine.2010.08.006_bib0055","first-page":"S143","article-title":"New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations","volume":"8","author":"Williams","year":"2002","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.006_bib0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0264-410X(96)00175-2","article-title":"Intranasal booster vaccination against diphtheria and tetanus in man","volume":"15","author":"Aggerbeck","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.006_bib0065","first-page":"437","article-title":"Perspectives on needle phobia","volume":"41","author":"McSherry","year":"1995","journal-title":"J Fam Pract"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0070","first-page":"169","article-title":"Needle phobia: a neglected diagnosis","volume":"41","author":"Hamilton","year":"1995","journal-title":"J Fam Pract"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0075","series-title":"First nasal mist flu vaccine approved","author":"FDA News","year":"2003"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.08.006_bib0080","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1345\/aph.1E191","article-title":"Trivalent intranasal influenza vaccine, live","volume":"38","author":"McCarthy","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2010.08.006_bib0085","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/423001","article-title":"Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5\u201349 years","volume":"39","author":"Belshe","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.08.006_bib0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0952-7915(94)90144-9","article-title":"Mucosal immunity to infection with implications for vaccine development","volume":"6","author":"Staats","year":"1994","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0100","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1073\/pnas.94.7.3284","article-title":"Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis","volume":"94","author":"Prakken","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.1996.tb08289.x","article-title":"Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal administration of synthetic peptide 184\u2013198 of bovine type II collagen (CII) expressing a dominant T cell epitope","volume":"103","author":"Staines","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/clin.1997.4432","article-title":"Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases","volume":"85","author":"Xiao","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.08.006_bib0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-5728(97)00133-1","article-title":"Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA","volume":"80","author":"Bai","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.006_bib0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005072-199803000-00010","article-title":"Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57\u201381","volume":"57","author":"Zhu","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2010.08.006_bib0125","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.4049\/jimmunol.0901445","article-title":"ADP-ribosylation controls the outcome of tolerance or enhanced priming following mucosal immunization","volume":"184","author":"Hasselberg","year":"2010","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.08.006_bib0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/eji.200636199","article-title":"Regulation of intestinal immunity: effects of the oral adjuvant Escherichia coli heat-labile enterotoxin on migrating dendritic cells","volume":"37","author":"Milling","year":"2007","journal-title":"Eur J Immunol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2010.08.006_bib0135","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.176.7.4275","article-title":"TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium","volume":"176","author":"Chabot","year":"2006","journal-title":"J Immunol"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2010.08.006_bib0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2004.12.008","article-title":"From toxin to adjuvant: basic mechanisms for the control of mucosal IgA immunity and tolerance","volume":"97","author":"Lycke","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1309.036","article-title":"ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity","volume":"December (1029)","author":"Lycke","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.153.2.647","article-title":"Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin","volume":"153","author":"Snider","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0155","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting Edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2010.08.006_bib0160","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.08.006_bib0165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.68.2.672-679.2000","article-title":"Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract","volume":"68","author":"Simecka","year":"2000","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.006_bib0170","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMp048006","article-title":"Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy","volume":"350","author":"Couch","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.006_bib0175","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2010.08.006_bib0180","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS One"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2010.08.006_bib0185","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.4049\/jimmunol.162.10.6141","article-title":"IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens","volume":"162","author":"Staats","year":"1999","journal-title":"J Immunol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.08.006_bib0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.76.2.517-524.2002","article-title":"Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization","volume":"76","author":"Bradney","year":"2002","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.006_bib0195","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-3083.1997.d01-159.x","article-title":"Nasal lymphoid tissue (NALT) as a mucosal immune inductive site","volume":"46","author":"Wu","year":"1997","journal-title":"Scan J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02786362","article-title":"Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system","volume":"16","author":"Wu","year":"1997","journal-title":"Immunol Res"},{"issue":"11","key":"10.1016\/j.vaccine.2010.08.006_bib0205","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/1521-4141(200211)32:11<3191::AID-IMMU3191>3.0.CO;2-0","article-title":"Structural and functional differences between putative mucosal inductive sites of the rat","volume":"32","author":"Zuercher","year":"2002","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.006_bib0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0105-2896.2005.00299.x","article-title":"Bronchus- and nasal-associated lymphoid tissues","volume":"206","author":"Bienenstock","year":"2005","journal-title":"Immunol Rev"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.08.006_bib0215","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"December (Suppl. 1)","key":"10.1016\/j.vaccine.2010.08.006_bib0485","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.ijporl.2003.08.018","article-title":"Immunology of tonsils and adenoids: everything the ENT surgeon needs to know","volume":"67","author":"Brandtzaeg","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.08.006_bib0225","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0002-9440(10)64841-9","article-title":"Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils","volume":"157","author":"Boyaka","year":"2000","journal-title":"Am J Pathol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2010.08.006_bib0230","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.157.1.462","article-title":"Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4\/V3 peptide T1SP10 MN(A)","volume":"157","author":"Staats","year":"1996","journal-title":"J Immunol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2010.08.006_bib0235","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.vaccine.2004.03.011","article-title":"A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques","volume":"22","author":"Egan","year":"2004","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.08.006_bib0240","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/IAI.70.10.5479-5484.2002","article-title":"Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines","volume":"70","author":"Janakova","year":"2002","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.08.006_bib0245","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1211\/jpp.58.4.0003","article-title":"Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice","volume":"58","author":"Sloat","year":"2006","journal-title":"J Pharm Pharmacol"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2010.08.006_bib0490","doi-asserted-by":"crossref","first-page":"L833","DOI":"10.1152\/ajplung.00173.2001","article-title":"Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia","volume":"282","author":"Southam","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.08.006_bib0255","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1213\/01.ane.0000216001.36932.a3","article-title":"The effect of sevoflurane on ciliary motility in rat cultured tracheal epithelial cells: a comparison with isoflurane and halothane","volume":"102","author":"Matsuura","year":"2006","journal-title":"Anesth Analg"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2010.08.006_bib0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines","volume":"1","author":"Aucouturier","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"April (Suppl. 2)","key":"10.1016\/j.vaccine.2010.08.006_bib0265","article-title":"The use of oil adjuvants in therapeutic vaccines","volume":"24","author":"Aucouturier","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines","volume":"1","author":"Aucouturier","year":"2002","journal-title":"Exp Rev Vaccines"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2010.08.006_bib0275","first-page":"483","article-title":"Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist","volume":"77","author":"von Uexkull","year":"1992","journal-title":"Immunology"},{"issue":"Fall (3)","key":"10.1016\/j.vaccine.2010.08.006_bib0280","first-page":"381","article-title":"Response of murine cell lines to an IL-1\/IL-2-induced factor in a rat\/mouse T hybridoma (PC60): differential induction of cytokines by human IL-1 alpha and IL-1 beta and partial amino acid sequence of rat GM-CSF","volume":"9","author":"Vandenabeele","year":"1990","journal-title":"Lymphokine Res"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.08.006_bib0285","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/eji.1830200333","article-title":"Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice","volume":"20","author":"Libert","year":"1990","journal-title":"Eur J Immunol"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2010.08.006_bib0290","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/1043-4666(94)90037-X","article-title":"Species-specific binding of IL-1, but not the IL-1 receptor antagonist, by fibroblasts","volume":"6","author":"Lederer","year":"1994","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.006_bib0295","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1399-302X.2002.170305.x","article-title":"Evaluation of interleukin 1 as a mucosal adjuvant in immunization with Streptococcus sobrinus cells by tonsillar application in rabbits","volume":"17","author":"Kokuryo","year":"2002","journal-title":"Oral Microbiol Immunol"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2010.08.006_bib0300","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1152\/jappl.1996.81.5.1878","article-title":"Importance of airway blood flow on particle clearance from the lung","volume":"81","author":"Wagner","year":"1996","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000150150","article-title":"Effective antibody therapy in herpes simplex virus ocular infection. Characterization of recipient immune response","volume":"31","author":"Lausch","year":"1990","journal-title":"Intervirology"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2010.08.006_bib0310","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1128\/IAI.61.10.4272-4279.1993","article-title":"Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant","volume":"61","author":"Jackson","year":"1993","journal-title":"Infect Immun"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2010.08.006_bib0315","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.4049\/jimmunol.161.8.4115","article-title":"A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A","volume":"161","author":"Yamamoto","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0320","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/IAI.65.2.640-644.1997","article-title":"Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection","volume":"65","author":"Yamamoto","year":"1997","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2010.08.006_bib0495","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1128\/IAI.71.12.7149-7153.2003","article-title":"Pneumococcal surface protein a is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis","volume":"71","author":"Swiatlo","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0330","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serlogical correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2010.08.006_bib0335","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1016\/j.vaccine.2007.05.002","article-title":"A dose\u2013response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults","volume":"25","author":"Atmar","year":"2007","journal-title":"Vaccine"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.08.006_bib0340","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms","volume":"191","author":"Mikszta","year":"2005","journal-title":"J Infect Dis"},{"issue":"July (11)","key":"10.1016\/j.vaccine.2010.08.006_bib0345","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/aid.1997.13.945","article-title":"Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses","volume":"13","author":"Staats","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.08.006_bib0350","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm1757","article-title":"Mast cell activators: a new class of highly effective vaccine adjuvants","volume":"14","author":"McLachlan","year":"2008","journal-title":"Nat Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.08.006_bib0355","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect Immun"},{"issue":"July\u2013August (6)","key":"10.1016\/j.vaccine.2010.08.006_bib0360","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/CJI.0b013e3181a80e0d","volume":"32","author":"Kouiavskaia","year":"2009","journal-title":"J Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.006_bib0365","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"3","author":"Wu","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2010.08.006_bib0370","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol Pathol"},{"issue":"February (2\u20134)","key":"10.1016\/j.vaccine.2010.08.006_bib0375","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.vetimm.2009.08.011","article-title":"NALT (nasal cavity-associated lymphoid tissue) in the rabbit","volume":"133","author":"Casteleyn","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2010.08.006_bib0380","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2005.04.002","article-title":"Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide","volume":"33","author":"Park","year":"2005","journal-title":"Biologicals"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.08.006_bib0385","first-page":"588","article-title":"Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test","volume":"9","author":"Nakagawa","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.08.006_bib0390","first-page":"73","article-title":"Comparative study of rabbit pyrogen test and human whole blood assay on human serum albumin","volume":"19","author":"Spreitzer","year":"2002","journal-title":"Altex"},{"issue":"14","key":"10.1016\/j.vaccine.2010.08.006_bib0395","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0264-410X(95)00074-B","article-title":"Parameters related to the application of recombinant ovine interleukin-1 beta as an adjuvant","volume":"13","author":"Lofthouse","year":"1995","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2010.08.006_bib0400","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.4049\/jimmunol.130.5.2191","article-title":"The adjuvanticity of interleukin 1 in vivo","volume":"130","author":"Staruch","year":"1983","journal-title":"J Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.08.006_bib0405","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1086\/513856","article-title":"Cytokines as endogenous pyrogens","volume":"179","author":"Dinarello","year":"1999","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2010.08.006_bib0410","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2006.02.024","article-title":"An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits","volume":"24","author":"Wimer-Mackin","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.08.006_bib0415","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1208\/pt0804081","article-title":"Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination","volume":"8","author":"Garmise","year":"2007","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00006231-199902000-00010","article-title":"Comparison of the clearance of radiolabelled nose drops and nasal spray as mucosally delivered vaccine","volume":"20","author":"Bryant","year":"1999","journal-title":"Nucl Med Commun"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2010.08.006_bib0425","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2010.08.006_bib0430","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4161\/hv.3.3.4011","article-title":"Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge","volume":"3","author":"Huang","year":"2007","journal-title":"Hum Vaccines"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2010.08.006_bib0435","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.vaccine.2008.12.013","article-title":"Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine","volume":"27","author":"Coucke","year":"2009","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2010.08.006_bib0440","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.08.006_bib0445","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/stem.140164","article-title":"Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects","volume":"14","author":"Veltri","year":"1996","journal-title":"Stem Cells"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.08.006_bib0450","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(91)90510-3","article-title":"Action site of circulating interleukin-1 on the rabbit brain","volume":"540","author":"Hashimoto","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.vaccine.2010.08.006_bib0455","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1113\/jphysiol.1990.sp018213","article-title":"Central action sites of interleukin-1 beta for inducing fever in rabbits","volume":"428","author":"Murakami","year":"1990","journal-title":"J Physiol"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2010.08.006_bib0460","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","article-title":"Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally","volume":"24","author":"Jaganathan","year":"2006","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2010.08.006_bib0465","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00602-0","article-title":"Clearance characteristics of chitosan based formulations in the sheep nasal cavity","volume":"217","author":"Soane","year":"2001","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.006_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2010.08.006_bib0475","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T17:48:49Z","timestamp":1711734529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":95,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10011151"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}